LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
0 hedge funds and large institutions have $0 invested in Landos Biopharma, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-16
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$31.9M |
| 2 |
DAM
Deltec Asset Management
New York
|
-$1.07M |
| 3 |
Renaissance Technologies
New York
|
-$406K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$316K |
| 5 |
VF
Virtu Financial
New York
|
-$313K |
